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Summary.-Two rapidly growing allogeneic tumours, sublines of Yoshida (Y-P388)
and Walker (W-256) injected intravenously in single cell suspensions produced
tumour macrocolonies in the lungs of rats within 7 days. Y-P388 produced similar
but fewer colonies in the kidneys. Colony forming efficiency (CFE) in lung was
high in weanling rats given either sublethal wholebody irradiation (WBI) or a single
doseofrabbit anti-ratlymphocytic serum (ALS) to suppressimmunity. Inimmuno-
logically intact weanlings CFE was much lower and many 7-day old colonies showed
signs of regression. CFE for primary tumour cell challenges decreased rapidly and
markedly with increase in age of host during the first 1-2 weeks after weaning. This
resistance to growth of a primary challenge in lungs of older rats was not signifi-
cantly reduced by WBI but was decreased by ALS. CFE of a secondary challenge of
tumour cells injected intravenously in rats which had been previously immunized
with heavily irradiated (HR) tumour cells was very low; it was not significantly
increased by WBI but was moderately increased by ALS. In weanling rats given
lethal (900 ra4) WBI, 1 hour before intravenous injection of tumour cells, treatment
with bone marrow (BM) cells derived from normal adult donors increased CFE,
whereas BM (or spleen) cells from immunized donors decreased CFE. The results
suggest that ALS and WBI not only increase tumour CFE by suppressing immunity
to tumour growth but also " condition " host tissue (tumour bed) in such a way as
to facilitate the survival, " take " and initial replication of grafted tumour cells
before the rats recover from the immunosuppressive effects of these treatments.
SINGLE tumour cells, prepared in
suspension from certain transplantable
ascites and solid tumours and injected
intravenously, have been shown to form
tumour macrocolonies in the lungs of
mice and rats (Zeidman, McCutcheon and
Coman, 1950; Baserga et al., 1960;
Williams and Till, 1966; Hill and Bush,
1960). The number of macrocolonies
produced was found to be proportional
to the number of cells injected, but colony
forming efficiencies (CFE) reported in the
literature varied considerably and were
relatively low compared with plating
efficiencies obtained in vitro (Williams and
Till, 1966). A low CFE was also obtained
in a syngeneic tumour-host system
showing little evidence of immunological
incompatibility (Hill and Bush, 1969),
and in individual animals injected with
the same number of cells colony numbers
did not conform to a Poisson distribution.
This paperdescribes intravenous assays
of two rapidly growing allogeneic tumours
(Y-P388 sarcoma and W-256 carcinoma)
which formed macrocolonies in the lungs
of the rat within 7 days after injection
and with high efficiencies. The effect of
immunosuppressive agentson colony form-
ing efficiency in hosts of different ages
have been studied, as well as the effects
of immunization and of treatment of
inoculated rats with normal or sensitized
bone marrow or spleen cells.MACROCOLONY ASSAYS IN THE RAT
MATERIALS AND METHODS
Tumours. The 2 ascites tumours, a
nitrogen mustard resistant subline (Y-P388)
of the Yoshida sarcoma and the Walker
(W-256) carcinoma, were used. These 2
tumours were obtained originally from Dr
T. A. Connors, Chester Beatty Institute,
London, and had been regularly passaged for
some years in female Caworth Farm Strain
(SPF) rats used in this laboratory exclusively.
Both tumours produced rapidly growing
solid, haemorrhagic growths (volume doubling
time 16-24hours) in muscle orinsubcutaneous
tissue, and they metastasized rapidly to
regional lymph nodes and lungs; Y-P388
tumour metastasized regularly in all rats but
only 50-70%O of rats inoculated with W-256
developed growing metastases. Y-P388 cells
measured 12-7 (10-8-13*5) ,tm mean diameter;
W-256 cells were larger, measuring 14-8
(13-5-16-2) ym diameter. Single cell suspen-
sions of either tumour inoculated intraven-
ously in 3_4 week old weanling rats, produced
blood red, raised macrocolonies (1-3 mm
diameter) in the lungs after 6-7 days'
growth. W-256 lung colonies were some-
what more discrete and larger than Y-P388
colonies (see Results). Intravenously inocu-
lated WV-256 cells rarely produced colonies
in the kidneys. Rats inoculated with Y-P388
cells consistently developed kidney colonies,
which were few in number but produced in
proportion to the number of lung colonies.
Whole body irradiation.-A twin headed
AMobiltron fitted with 60Co sources was
used for whole body irradiation (WBI). The
technique has been described previously
(van den Brenk, Moore and Sharpington,
1971a).
Intravenous assay of tumour cells. All
intravenous inoculations were standardized
by injecting the required number of cells
suspended in 0 5 ml ice cold Tyrode solution
(pH 7 6) into a lateral tail vein of the rat.
Weanling (3-4 week old) female rats of a
specific pathogen-free (SPF) derived colony
of the Caworth Farm Strain were used for
most assays. They were exposed to 570 rad
(WBI) less than 24 hours preceding inocula-
tion, or were given 0 5 ml rabbit anti-rat anti-
lymphocytic serum (ALS) intravenously on
one or more successive days to suppress
immunity. ALS serum was supplied by
Burroughs Wellcome Ltd and had been
prepared using rat thymocytes. The serum
was not exposed to rat erythrocytes or other
normal cells before use, in order to preserve
maximumimmunosuppressive potency. The
first dose was given intravenously 1 day
preceding inoculation or on the day of inocu-
lation. Repeated doses of ALS caused a
high incidence of renal damage as reported
by others (see Guttmann et al., 1967) and
20-40o% of the rats died within 2 weeks.
Rats inoculated with tumour were deeply
anaesthetized 7 days after inoculation, exsan-
guinated and the abdomen and thorax were
opened widely. The total number of macro-
scopically visible tumour colonies present
on the external surfaces of both lungs was
counted and a similar count was made for
both kidneys in each rat. The thymus and
spleen were usually removed and weighed.
A group of not less than 6 rats was used for
each point of an assay. The donor tumour
cells were provided by freshly harvested
ascites fluid which was diluted and counted as
described previously (van den Brenk et al.,
1971a). To study the effect of age of reci-
pient on colony forming efficiency, both
male and female rats, aged from 28 to 63 days
on the day ofsacrifice, were used.
HR tumour cells.-These were prepared
as described previously by exposing freshly
harvested heparinized tumour ascites fluid
in plastic dishes to a single dose of 6000 rad
to destroy cell proliferative potential and
clonogenicity. Intravenous injection of 106
cells of these irradiated cells produced an
average of <1 lung colony per rat. HR
cells were used to increase immunity to
tumour growth in rats by injecting the
animals intramuscularly with 107 HR cells
twice weekly for 3 weeks.
Colony assays.-The mean number of
lung colonies (NL) or kidney colonies (NK)
present 7 days after inoculation was plotted
as a function of the number ofintravenously
inoculated cells (N). It was found that if N
exceeded 104 cells, NL was too high (>200) in
immunologically suppressed weanling recipi-
ents to count colonies with sufficient accuracy
since many colonies had become confluent.
The presence ofalargenumberoflungcolonies
also caused marked increases in lung weight
due to tumour growth which induced focal
haemorrhage and oedema. Colony forming
efficiency was defined as the mean number of
macrocolonies present on the surfaces of
lungs or kidneys which was produced for
each cell inoculated.
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Spleen and bone marrow cells and macro-
phages.-Suspensions of spleen and bone
marrow cells were prepared from spleens or
from femoral and tibial bone marrow plugs
respectively, which had been removed either
from unimmunized or immunized donor rats.
These cell suspensions were prepared in
appropriate dilutions in heparinized ice-cold
Tyrode solution in the usual way and were
used to treat rats which had been inoculated
with tumour cells intravenously. Peritoneal
macrophages were harvested from rats 5 days
after injecting 5 ml of6% Na caseinate intra-
peritoneally (Patterson, Pisano and Di Luzio,
1970).
Splenectomy.-Under pentobarbitone
sodium anaesthesia, the spleen was removed
through a left subcostal incision and the
wound approximated in layers with sutures
and metal clips. Rats were inoculated with
tumour cells 2-3 days after operation.
Histological studies-Formalin fixed
tissues were embedded in paraffin; 5-7 ,m
thick sections were cut and stained by
haematoxylin and eosin or the van Gieson
technique. The Unna-Pappenheim and acri-
dine orange methods for staining nucleic
acids were used to assist in the identification
of plasma cells in tissue sections.
ED50 for tumours.-The 2 tumours were
inoculated intramuscularly in the gastrocne-
mius in 0-1 ml volumes containing from
5to 5 x 106tumourcells. Agroupof 5-6rats
which were immunologically intact, immuno-
logically attenuated (570 rad WBI) or which
had been immunized (107 HR tumour cells
twice weekly for 3 weeks) respectively were
used for each cell dose inoculated. The
number of cells required to induce a palpable
growing tumour within 4 weeks in 50% of
rats (ED50 value) was calculated.
RESULTS
1. ED50 values for intramuscular inocula-
tion of Y-P388 and W-256 tumours
Whereas a primary challenge of only
a few (<10) W-256 cells was required to
induce progressive growth in immuno-
logically intact rats, -'5 x 103 Y-P388
cells were required (Table I). Suppres-
sion of immunity by sublethal WBI (or
ALS) lowered ED50 values for the 2
tumours to -.5-10 cells. Immunization
TABLE I. Changes in ED50 Values for
Y-P388 and W-256 Tumour Inocula-
tions in muscle of 6-week old Female
Recipient Rats due to Immunological
Suppression (WBI 570 rad or treatment
with ALS) and Immunization (107 HR
cells injected Twice Weekly for 3 weeks
or Growth of Intact Cells as Primary
Challenge)
Treatment
Nil
WBI
ALS
HR cells
Growth of tumour*
ED50 (number of cells)
Y-P388 W256
,5 X 103 <10
<10 <5
<5 <5
, 5 X 105 , 106
> 106 > 106
* ED50 for second challenge in rats with 7-day
old growing solid tumour induce(d by primary
challenge (105 cells).
raised values to 105_1l06 cells. ED50
values for the 2 tumours in muscle did
not change significantly with increase
in age of host. Indeed, the rate of
growth of these tumours in muscle had
been found to increase with age, a finding
which will be reported in further detail
in relation to effect of age on relative
growth rates of primary Y-P388 tumour
and its metastases.
2. Tumour macrocolony formation in lungs
and kidneys
In weanling (3-4 week old) female rats
inoculated intravenously with either
Y-P388 or W-256 tumour cells, lung and
kidney colony counts (NL, NK) obtained
have been plotted as functions of number
of cells injected (N) on a log-log scale (Fig.
1). The relationships are essentially
linear, such that
NL- kN0
where 0 and k are constants for Y-P388
tumour cells; the value of exponent 0
approximates to 0 7 for both lung and
kidney colony production, and in both
unirradiated and irradiated rats. W-256
produced no kidney colonies, even after
injecting 104 or more cells which caused
confluent and consolidative growth of
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FIG. 1.-Number of macrocolonies present 7 days after inoculation in lungs (NL) and kidneys (NK)
of irradiated (closed symbols) and unirradiated (open symbols) weanling rats plotted as a function
of number of Y-P388 or W-256 tumour cells (N) injected intravenously. Each point represents
mean (±SE) for a group of 6-8 rats.
tumour in the lungs and considerable
increases (two-three-fold) in lung weight.
As a result, a proportion of such rats died
within 7 days. For W-256, 0 was higher
(0.93) and was not significantly different
for unirradiated and immunosuppressed
recipients.
Less efficient colony production by
both tumours occurred in immuno-
logically intact rats. The number of
Y-P388 cells injected had to be increased
by factors of 0-8 and 1*8 to increase NL
and NK respectively to the same values
as were obtained in irradiated rats; for
W-256, an 0 7 increase in log N was
required in unirradiated rats to raise lung
colony production to that in irradiated
rats.
Y-P388 macrocolonies in kidney had
the same appearances and were similar
in size to those in lung but were fewer in
number (NK
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and NK
- 002 INL ilnimmunologically
intact rats). Colonyproduction for W-256
increased linearly with increase in the
number of cells injected, since 0 (W-256)
0 93 and approximated to unity but
the rates of increase in NL and NK for
Y-P388 (0 0 72) were not linear. The
greater proportion of Y-P388 cells than
the larger W-256 cells, which escape arrest
iii the lungs, may help to account for the
lower values of () obtained for Y-P388
tumour cells.
Besides increasing NL and NK, immu-
nosuppressive treatments also caused
Y-P388 and W-256 lung colonies to differ
in size and appearance. In irradiated
recipients, the colonies were larger and
more uniform in size, were redder due to
the presence of more blood and their
growth caused greater increases in lung
weight. In unirradiated recipients, lung
colonies (particularly Y-P388 colonies)
were paler and browner in colour and
flattened. These signs of regression of
growth were seen as early as 7 days after
inoculation of weanling rats. The lung
tissues surrounding regressing colonies
were frequently depressed, in the form of
a moat arouind each colony, and caused
umbilication (Fig. 2). More marked signs
of tumour regression occurred in older
rats and particularly if colonies were
allowed to grow for longer than 7 days.
Fuirther colony regression gave rise to
pitting of the pleural surface due to focal
atelectasis, with overlying small adherent
plaques of fibrinous exudate and later
still complete regression gave rise to
discrete white scars, pinpoint in size
(Fig. 2).
In irradiated weanling rats tutmour
colony counts were slightly lower than in
rats treated with ALS. A few experi-
ments in which rats received WBI com-
bined with ALS, NL an(l NK for Y-P388
were slightly raised btut this treatment
proved hiighly lethal and caused 20-30%
of rats to die within 7 days. Y-P388 and
W-256 colonies in lungs differed in their
histological appearances (Fig. 2). The
latter were epithelioid in structure, more
discrete and there was less infiltration of
adjacent lung tissues by tumour. Special
stains were used for plasma cells and
india ink was injected intravenously to
label macrophages intravitally. Neither
growing nor regressing lung tumour colo-
nies showed significant evidence of infil-
tration by lymphocytes, plasma cells or
macrophages. More tumour cells in
regressing colonies showed pyknotie and
lytic changes but most tumour cells
appeared viable on histological grounds
and dividing tumour cells (mitosis) were
usually seen. The free blood (haemorr-
hage) had largely disappeared in regres-
sing colonies, and progressive reparative
fibrosis was the principal change shown
by such colonies in lung and kidney.
It was difficult to lay down strict
criteria which defined clonogenicity of
tumour in terms of macrocolony forma-
tion, since colonies differed in size. Even
if clear evidence of initial take andgrowth
of inoculated cells could be deduced
by the presence of colonies, regressive
changes caused alterations in both macro-
scopic and microscopic appearances.
In the present study a macrocolony was
arbitrarily defined as a discrete, raised
colony, 1 mm or more in diameter, visible
to the naked eye on the pleural surface.
Any evidence of regression was ignored
except if residual pitted and scarred
lesions were present, which were not
scored. Lung colony counts were made
in 2 groups of 10 female and 10 male 32-
day old rats (litter maters obtained from
4 litters born on the same day), which had
been givein 570 rad WBI and inoculated
with 5 x 102 W-256 cells. There was no
significant difference. The pooled data
for NL in both sexes (Fig. 3) did not show a
Poisson distribution (see Discussion).
Results in Fig. 3 show that NL was
73 ± 9 in females and 71 ± 9 in males.
This data pooled for the male and female
rats used in this experiment gave a mean
value NL- 72, i.e. a colony forming
efficiency of 0-14. This value is high
compared with a maximum efficiency of
0 03 obtained by Hill and Bush (1969) for
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FIG. 2.-Appearances ofW-256 and Y-P388 tumour colonies in lungs of rats 7 days after intravenous
injection of tumour cells. A. Unfixed lungs and kidneys of 6-week old rats injected with 104
Y-P388 cells: left, after rats had been immunized with HR cells (see text) showing no colonies;
centre, primary challenge in unirradiated rats, showing small pale regressing colonies in lungs;
right, actively haemorrhagic colonies in lungs and kidneys of rats given 570 rad WBI 24 hours
before inoculation. B. W-256 colonies on surface of formalin fixed lung from unirradiated rat;
many colonies show regression causing umbilication (U) and the adherence of fibrinoid material
(F). C. Histological appearances of W-256 colonies (x 30). D. Histological appearances of
Y-P388 colonies (x 30).
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FIG. 3. Lung colony counts obtained in 2 groups
of 10 female and 10 male 32-day old rats given
570 rad WBI before inoculating 5 x 102 W-256
cells.
a syngeneic system in the mouse, obtained
by adding HR cells in excess to the inocu-
lum which caused NL to increase twenty-
thirty-fold.
Despite the high colony forming
efficiency, the data in Fig. 3 show that
the variance greatly exceeded the mean.
Similar high variances were obtained
when ALS was used instead ofwhole body
irradiation to suppress immunity or when
certain other procedures were used to
increase values of NL, namely, by adding
HR cells to the inoculum, locally irradiat-
ing the lungs before the inoculation of
tumour cells or combining WBI with
steroid therapy (see below).
3. Effect of age of recipient on colony pro-
duction
One hundred and twenty 26-30 day
old female rats were randomized into 16
groups (6-8 rats per group) at the onset
of an experiment designed to determine
the effect of age ofrecipient on the produc-
tion of lung colonies by intravenously
injected Y-P388 tumour cells. Eight
groups received 570 rad WBI, <24 hours
preceding the injection of tumour cells;
the other 8 groups were not irradiated.
At 4 different ages (3-8 weeks) all rats
in an unirradiated and an irradiated
group were injected with 5 x 102 Y-P388
cells per 100 g body weight and 2 such
further groups received 5 x 103 cells per
100 g body weight. All rats were killed
7 days after inoculation when mean rat
body weights ranged from 85 to 205 g
(corresponding to a 5-week increment in
age of rats). NL and NK in both unirra-
diated and irradiated rats decreased
rapidly with increase in age, particularly
so during the fifth to sixth week (Fig. 4).
W-256 lung macrocolony production in
irradiated rats was similarly dependent
on age and not affected by sex (Fig. 5).
In this experiment, 108 female and 90
male rats were given sublethal WBI
and injected with 5 X 102 W-256 cells.
Colony formation decreased even more
rapidly (approximately ten-fold) during
the sixth week of post-natal life. Resist-
ance to clonogenicity of tumour in the
lungs with age could not be attributed
simply to increase in body weight (and
increased lung volume) since males grew
considerably faster than females during
the course of the experiment (see Fig. 5).
In this strain of SPF rats, weight of
most organs (w), including that ofthymus,
can be expressed in terms of body weight
(W) as an allometric function (van den
Brenk, Sparrow and Moore, 1969), given
by the equation of Huxley (1932):
w _aWf
where ax and / are constants. In females,
the thymus shows positive growth
(, + 1.33) until about the sixth week
(130 g body weight) when it commences to
regress and causes growth (in an allo-
metric sense) to become negative,
(,l=
-1.43), with further ageing. In
males, regression of the thymus is delayed
until about the eighth week of age.
Consequently in both sexes the age of
onset of thymic regression did not corre-
late with the development of resistance
to take and growth of tumour cells in the
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FIG. 4. Numbers of tumour macrocolonies produced in lungs (NL) and kidneys (NK) of female rats of
different ages, 7 days after 5 x 102 or 5 x 103 Y-P388 cells/100 g body weight had been injected
intravenously; unirradiated rats (open symbols), after 570 rad WBI (closed symbols), 6-8 rats
per point.
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FIG. 5. Tumour colonies produced in lungs of male and female rats of different ages 7 days after
intravenous injection of 5 x 102 W-256 cells (upper figure). Lower figures show corresponding
changes in mean final body weight, and in spleen and thymus weights (open symbols used for
males, closed symbols for females). In lower figures the small symbols and interrupted lines
represent organ weights corresponding to mean final body weight in untreated control rats; in
left figure the body weight/age curves for normal males (M) and females (F) of this strain of rats
are shown as uninterrupted lines. In all 4 graphs the larger circular symbols are for rats given
570 rad WBI, square symbols are for rats given a single i.v. injection (0.5 ml) of ALS before
tumour inoculation, and the triangular symbols are for inoculation of rats which had received
neither irradiation nor ALS (6 rats per point).
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lungs; nor were allometric, and hyper-
plastic, increases inweight ofspleenrelated
to susceptibility to tumour growth (see
below).
The results in Fig. 5 also show that
unirradiated, recently weaned rats were
much more resistant to growth of tumour
in lungs (NL 19 ± 5) than irradiated
rats of the same age (NL - 91 ] 10).
When weanling rats were similarly
irradiated but not injected with tumour
cells until 14 days later (when 40 days old)
NL was significantly higher than in 40-day
old rats irradiated immediately preceding
injection of the same number of W-256
cells (Table II), although the value
obtained (NL 57 ± 13; N 103 cells)
was lower than in recently weaned rats
irradiated immediately before injection
of tumour cells (see Fig. 1). Much ofthis
decrease could be accounted for by the
presence in the older rats of " micro-
colonies " which were not scored. Four-
teen days after irradiation the weight of
spleen in inoculated rats had recovered
and increased to double that of normal
rats of the same body weight, but the
thymus remained -40% lower in weight
than normal.
4. Arrest of body growth
A further experiment was made to
determine whether increase inbody weight
per se could account for resistance to
tumour growth in lungs with increase in
age of rats. The growth of 5-week old
rats was stunted and their body weight
reduced to that of 4-week old rats by
restricting the dietary intake for 7 days
to tapioca (supplemented with vitamins)
with water ad libitum. This caused a
mean body weight loss of 34 g per day
compared with a similar rate of gain in
weight on a normal diet. After 7 days on
restricted diet the rats were given WBI
and inoculated with 2 x 102 W-256
tumour cells and replaced on a normal
diet. This caused mean rat growth rate
during tumour growth (5 g per day) to
exceed normal (,3.5 g per day). How-
ever, colony forming efficiency was only
0-012 and similar to the value 0-014
obtained in unstarved rats ofthe same age
(49 days), whereas much higher values of
0 155 and 0 180 were obtained in 35- and
42-day old rats respectively (Table III).
Consequently, resistance to lung colony
growth oftumour is associated with ageing
and is not dependent on body weight.
5. Effects of treatment with ALS serum
In older (56-day old) rats given a
single intravenous injection of 0'5 ml of
ALS, the incidence oflung tumour colonies
was comparable to that in weanling rats
given ALS or WBI (Fig. 5) i.e. in both
sexes ALS but not irradiation had reversed
resistance to clonogenic growth of a primary
challenge of W-256 and Y-P388 tumours
in the lungs, which develops with increase
in age of rat whereassu blethal whole body
irradiation failed to do so. Thus, in
56-day old rats injected with 5 x 102
W-256 cells, colony forming efficiency
increased from 0 009 (after WBI) to
0-234 (after ALS), i.e. approximately
TABLE II.-Effect of WBI (570 rad) given Immediately or 14 Days Before Intravenous
Inoculation of Female Rats (Litter Mates) with 103 W-256 Cells when Rats were 6
weeks Old
Radiation-
inoculation
interval
(days)
0
14
Final body
weight (g)
147
121
Number of
lung
colonies
9±3
57±13
Spleen
weight (g)
0 34
(0- 219)*
0-80
(O 640)*
Thymus
weight (g)
0-19
(0 122)*
0-18
(0- 144)*
* Mean weights of spleen and thymus expressed per unit body weight ( x 102) shown in brackets.
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TABLE III.-Colony Counts (NL) and Organ Weights Compared for Rats on Unrestricted
Diet Inoculated at 42 Days of Age (Group A) with those in Younger Rats Inoculated
at 35 Days (Group C) and at 28 Days (Group D) Respectively, and with Rats Inoculated
at 42 Days, whose Weight had been Reduced by Restriction of Dietfor 1 Week Preceding
Inoculation (Group B). All Rats were given 570 rad WBI 24 hours Preceding Inocula-
tion of 2 x 102 W-256 Cells and were Killed 7 Days Later. Ascites Tumourfrom a
Single Donor Rat was used to Inoculate Rats in all 4 Groups on the Same Day. Column
W1 shows Ages and Body Weights at the Time of Inoculation, Ws the Ages and Body
Weights 7 Days later when Rats were Killed
Age in days
(Body weight Wg)
A
35
(111±1)
35
(110± 1)
WI
42
(131± 2)
42
(86± 1)
Ws
49
(152±4)
49
(121±2)
Change in Mean Body
Weight
t 'I
7 days 7 days
preceding after
inoculation inoculation NL
W42-W35 W49-W42 2*8±
=+20g =+21g 0-7
W42-W35 W49-W42 2*4±
=-24g =+35g 0 7
Mean Organ
Weight g
(per unit body
weightgg-1 x102)
Spleen Thymus
0-24 0-20
(0-157) (0-131)
0-24 0-20
C 28 35 42 W35-W28 W42-W35 36±8 0 26 0 22
(69+0 5) (109±1) (131±2) =+40g =+22g (0.198) (0-167)
D 28 35 W35-W28 31±4 0-20 0-14
(70±0 5) (93±1) =+23g (0-215) (0.150)
Diet restricted to tapioca and water (ad libitum) with added vitaminsfor one week before tumour inoculation
only to reduce body weight. Groups A, C and D received balanced diet ad libitum throughout.
twenty-five-fold. This effect of ALS was
accompanied by marked increases in
weight of spleen and thymus of rats of all
ages, in contrast to marked decreases in
weight ofthese organs persisting at 7 days
after WBI.
6. Immunized recipients
Lung and kidney colony production by
Y-P388 cells injected intravenously as a
secondary challenge in rats immunized
with HR tumour cells were markedly
reduced (Table IV). In a similar experi-
ment in 40-day old immunized rats
injected with 104 Y-P388 cells, lung
colony production (NL 3 ± 0.7) was
not increased by sublethal WBI given
immediately preceding the inoculation
(NL 2 ± 0.5). In older rats immunized
TABLE IV.-Effects of Immunization with Heavily Irradiated (HR) Y-P388 Cells on
Tumour Colony Formation in Mature Female Rats (160-190 g Body Weight) Inoculated
with 103 or 104 Y-P388 Cells Intravenously. Group A, Whole Body Irradiation
(570 rad) 24 Hours before Inoculation; B, no Irradiation; C no Irradiation but given
5 x 107 HR Cells Twice Weekly for 3 Weeks Preceding Inoculation. Six Rats per
Group Killed 7 Days after Inoculation
Number of tumour
cells inoculated
intravenously
103
104
Number of lung colonies
Group A Group B Group C
16±4
(0 8; 0-3)*
141± 39
(7 0; 1-20)
10±2
(0 2; 0-1)
17±5
(0 5; 0-2)
1 3±0 6
(0 2; 0-1)
0 3±0 2
(O 0)
* Figures in brackets represent mean number (and ranges) ofsubcapsular tumour colonies in kidneys.
Group (10
rats per
group)
A
B
(Tapioca
diet from
35-42 days
of age only)
28
(71±0-5)
28
(71±0-5)
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with HR tumour cells, or by growth of
tumour in muscle (see Table I), a single
dose of ALS was only slightly more
effective than WBI in increasing the yield
of lung colonies produced by an intra-
venous inoculation of the tumour (second
challenge). When the number of ALS
injections was increased to 3-5 doses
before and after inoculation ofthe tumour,
tumour colony production efficiencies rose
to -005 (Y-P388) and --0.10 (W-256) in
those rats surviving 7 days after inocula-
tion.
7. RES and age-dependent changes in
tumour colony production
Since WBI and ALS treatment are
proven immunosuppressive treatments
which modified clonogenic growth of
these allogeneic tumours in lungs of rats,
it seemed likely that some function(s) of
the reticuloendothelial system (RES)
might be implicated. Therefore, various
supplementary experiments were per-
formed using either 3-4 week old or older
animals, and treating the rats before or
after inoculation with steroids or cytotoxic
chemicals or by splenectomy preceding
inoculation. Treatment of animals with
compound 48/80 to deplete tissue amines
(Feldberg and Talesnik, 1953) has been
found to increase growth of a heterologous
tumour in rats (van den Brenk and Upfill,
1958) and to increase survival of skin
homografts in rats (Boyd and Smith,
1960). Its effect on tumour colonygrowth
was also studied. Most of these data are
not given in full but are summarized to
indicate whether or not any significant
changes in colony forming efficiency were
produced.
(a) Steroids: Compound 48/80. Daily
treatments with hydrocortisone (10 mg/kg)
or dexamethasone (10 mg/kg) given intra-
muscularly, commenced 2 days before
tumour inoculations and continued for
5 days afterwards, did not significantly
alter the resistance of older rats to
clonogenic growth of the tumours in lung
or kidney. To deplete tissue biogenic
10
amines compound 48/80 was injected
intraperitoneally (daily) for 5 days. The
first dose given was 100 jig and this was
progressively increased by 100 pg per day,
to a final dose of 500 pg on the fifth day,
when rats were inoculated 4 hours later
with 103 W-256 cells. This treatment
had no effect on CFE in either young or
old rats.
(b) Chemotherapeutic agents.- Five
doses of cyclophosphamide (20 mg/kg)
or hydroxyurea (250 mg/kg) given intra-
peritoneally to rats over 7 days preceding
tumour inoculation did not increase lung
colony production significantly in older
rats and were much less effective than
WBI in weanlings.
(c) Splenectomy.-Splenectomy, 2-3
days before irradiation did not increase
colony formation. When it was supple-
mented by WBI or local irradiation (1500
rad) to the thymus, splenectomy did not
reverse age-dependent resistance to growth
of Y-P388 or W-256 tumour cells in the
lungs.
(d) India ink.-Quantitative studies
of the granulopectic activity of the RES
in rats have shown that loading of phago-
cytes with india ink reduces their capacity
to remove further ink from the circulation,
and produces a state of " saturation "
which causes phagocytic function to
deteriorate (Biozzi, Benacerraf and Hal-
pern, 1953). Pretreatment of rats with
a single large intravenous injection of
0 3 ml of india ink (Pelikan) given with a
view to inhibiting the functions of macro-
phages present in the various tissues ofthe
rat, had no significant effect on CFE,
neither in weanling nor in older rats.
(e) Whole body radiation dose.-The
whole body dose was increased to 900 rad
in weanling rats and in older rats. Six-
week old rats survived but a third of the
weanlings had died within 7-10 days.
Increasing the WBI dose did not increase
tumour colony yields in older rats and
fewer colonies were formed in weanling
rats which survived than were seen after
570 rad. However, 900 rad caused early
diarrhoea and rats lost weight very
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rapidly. This must be taken into account
since inanition and severe loss of weight
caused by irradiation or other treatments
invariably inhibited the take and growth
of these tumours in lungs and also their
growth rates in muscle.
8. Adoptive immunity
In 3-week old rats given 900 rad WBI
a large number (1.5 x 107) of bone
marrow cells harvested from normal 8-10
week old donor rats, were injected intra-
venously 1-2 hours after 102-105 Y-P388
tumour cells had been injected by the
same route. The same treatments were
given in parallel groups of rats using bone
marrow cells harvested from donor rats
previously immunized with HR tumour
(Y-P388) cells. The results are shown in
Fig. 6. Treatment with normal bone
marrow cells caused NL to rise significantly
in rats injected with 103-105 cells and
produced corresponding increases in lung
weight but significantly reduced colonies
formed by a small (102) cell inoculum.
Bone marrow cells from immunized donors
caused significant reductions in NL and
NK after 102-105 cells had been injected
and corresponding reductions in lung
weight. It is suggested that reductions
in clonogenicity of tumour cells in lungs
(and kidneys) by a large number of
sensitized bone marrow cells is due to an
adoptive immunity. Normal bone marrow
cells are less efficient in this respect and
are only effective in reducing growth of
relatively fewer injected tumour cells, but
give rise to a secondary " growth stimulat-
ing" effect which predominates when a
larger number of tumour cells are present
and apparently capable of exhausting the
immune component (see Discussion).
Similar experiments were conducted
with excesses of spleen cells, lymphocytes,
thymocytes or peritoneal macrophages
(106-107 cells) but these were added to
each tumour cell inoculum. Spleen cells
were obtained from 3-4 week old or
8-10 week old donors, or from 6-week old
immunized donors. The recipients were
weanling rats given 570 rad WBI. Nor-
mal spleen cells reduced tumour colonies
produced in lungs and kidneys by 102-104
Y-P388 cells by approximately 20%,
donor spleen cells from young and old rats
being equally effective; immunized spleen
cells reduced colonies formed by 104
tumour cells by approximately 5000.
Similar experiments with lymphocytes,
thymocytes and macrophages had no
significant effects on colony production.
These results will be reported later.
DISCUSSION
Lung colonies produced by tumour
cells injected intravenously have been
described as " metastases ". Clearly, this
term should not be used since the forma-
tion of metastases is a spontaneous event
which depends primarily on the exfolia-
tion of cells from a solid tumour and their
capacity to enter lymph and blood vessels.
However, arrest and growth in the lungs
of tumour cells injected intravenously
do provide a means for studying certain
pathophysiological mechanisms involved
in the formation of metastases. Colony
forming efficiencies (CFE) reported for a
variety of transplantable tumours (Table
V) are comparatively low even if an
immunosuppressive agent (WBI) had been
used in syngeneic hosts to decrease their
resistance due to possible antigenicity
of tumour (Hill and Bush, 1969). Low
CFE, taken in conjunction with their
finding that CFE in syngeneic mice
increased thirty-fold if an excess of
radiation sterilized (HR) tumour cells
or plastic microspheres were added to the
viable cell inoculum, suggests that factors
other than transplantation immunity may
affect take and clonal growth of tumour
cells present in the blood of an animal.
Clarification ofthese factors would appear
to be of considerable importance to the
understanding of metastasis formation.
Many clinical studies have demonstrated
the presence of cancer cells in the blood of
patients. Yet metastases may not develop
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FIG. 6.-Effect of treatment with bone marrow cells on tumour colony counts in lungs (NL) and kidneys (NK) of weanling rats 5 or 7 days after intravenous injection of Y-P388 cells. All rats received WBI immediately preceding inoculation of tumour anc were killed 5 or 7 days after
inoculation. Key to symbols: 570 rad WBI (previ us data, see Fig. 1)
- ---- 900 rad WBI
---- A -- -- 900 rad WBI (1-5 x 107 normal rat bone marrow
cells injected intravenously 1 hour
after tumour cells)
---- 900 rad WBI (1-5 x 107 sensitized rat bone marrow
cells injected intravenously 1 hour
after tumour cells). On the fifth day after inoculation some rats from groups inoculi ted after 900 rad WBI but not treated with bone marrow, had died (see survival data in Fig. 6); t e survivors were moribund and killed on this day to measure NL (NK could not be measured because presence of kidney colonies
was masked by renal congestion). Rats in all other groups were killed on the seventh day to
measure NL and NK-
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TABLE V. Tumour Colony Forming Efficiency (CFE Mean Number of Macrocolonies
Produced in Lungs (NL) per Tumour Cell Injected Intravenously) Reported in Literature.
N number of Tumour Cells Injected; Exponent 0 Calculatedfrom the Data if N- k1NLO
(see Text)
Tumour
Ehrlich tumour
Polyoma virus
transformed (f12)
rat cells
KHT sarcoma
Y-P388 sarcoma
W-256 carcinoma
IV Host
9 16 (x 105)* unirradiated 4-6
month old mice
(allogeneic)
2-5 (± 103) weanling rats
(allogeneic)
(a) irradiated
(b) unirradiated
1_15 ( x 102) unirradliated 5-7
week old C3H mice
(syingeneic)
102_105 irradiated weanling
rats (allogeneic)
103103 irradiated weanling
rats (allogeneic)
CFE 0 Reference
< 0 0001 3 - 28 Baseirga et atl. ( 1960)
..0* 015 1*03 Williams an(l Till (1966)
<0 005
0*001 0* 92 Hill andl Bush (1966)
(,0 03 by
a(l(ling HR cells)
>0.01 0-72
>0-1 0 93
* Values of N tused t(o calculate 0 which produced one oi more lung colonies in all mice injected; mice
injected writh ~ 9 x 104 Ehrlich cells rarely developed visible lung colonies :30 (lays later.
under conditions in which evidence of
autoimmunity to tumour growth is lacking
and this suggests that the mechanisms
which provide surveillance and defence
against circulating tumour cells are not
entirely attributable to classic immune
reactions.
Hewitt (1953) showed that C3H suck-
ling mice inoculated subcutaneously with
very small numbers of allogeneic (S37)
tumour cells were as highly susceptible
to growth of this tumour as to growth of a
syngeneic C3H sarcoma. However,
susceptibility to S37 decreased rapidly
with increase in age (particularly during
the first week of life), whereas suscepti-
bility of older mice to take and growth of
the syngeneic tumour remained high.
Similar experiments of our own with
Y-P388 and W-256 tumours transplanted
intramuscularly in rats have shown that
ageing caused no significant decrease in
susceptibility to growth of either tumour
in muscle. ED50 values after weaning
were relatively constant, --'5 x 103
Y-P388 cells and <10 W-256 cells respec-
tively. On the other hand, take and
clonogenic growth of cells of the tumours
in lungs of rats based on macrocolony
formation decreased relatively rapidly
with increase in age after weaning, even
when rats had been exposed to sublethal
WBI to suppress their immunity a treat-
ment which reduced the ED50 value for a
primary challenge of Y-P388 tumour
in muscle to <10 cells and greatly
increased lethality and growth of metas-
tases produced by this tumour in lymph
nodes and lungs (van den Brenk et al.,
197la). Resistance to growth ofa primary
challenge of Y-P388 or W-256 cells in the
lungs caused by ageing of host, however,
could be largely eliminated by heterolo-
gous anti-rat lymphocytic serum (ALS).
In transplantation systems ALS is a
powerful immunosuppressive agent
(Woodruff, 1960), the most powerful
yet described, but its exact mechanism of
action remains uncertain (Levey and
Medawar, 1966). Primarily its action in
this respect has been variously attributed
to lymphocytolysis, acting as a com-
petitive antigen, coating and " blind-
folding " lymphocytes so as to prevent
recognition of antigen by lymphocyte, or
to some other effects but the result of
its actions in vivo is " to weaken the
reactive capabilities of already sensitized
animals to a degree that approaches a
complete erasure of immunological
memory " (Levey and Medawar, 1966).
This effect of ALS of suppressing the
secondary immune response to the growth
of an allogeneic tumour transplanted in
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mice which had previously rejected a
tumour transplant has been demonstrated
by Riches and Thomas (1970), who also
showed that sublethal WBI was ineffec-
tive in this respect and would only
suppress immunity to a primary challenge
of the tumour. In our own system older
rats reacted to a primary intravenous
challenge with tumour cells like " sensi-
tized " animals since resistance to tumour
growth, which increased spontaneously
with increase in age of host, could be
suppressed by ALS but not by WBI.
On the other hand, the resistance of
both weanling and older rats to a primary
clhallenge of Y-P388 tumour in muscle
was reduced by either WBI or ALS; irrad-
iation did not significantly reduce the
secondary response of the host to tumour
growth in muscle whereas ALS did so
but not completely (unpublished results).
The finding reported by Fisher, Soliman
and Fisher (1969) that ALS enhanced take,
growth and metastasis ofmouse mammary
tumours in syngeneic C3HB/FeJ hosts
is also of interest in this respect. Certain
other findings also appear relevant to the
mode of action of immunosuppressive
agents against growth of syngeneic and
allogeneic tumours. Thus Patterson etal.,
(1970) consider that their experiments
point to the macrophage beingthe primary
cellular site of ALS induced immuno-
suppression. Other workers have pro-
vided evidence that ALS destroys or
neutralizes the functions of a variety
of circulating and fixed tissue cells other
than lymphocytes, including other leuco-
cytes, splenic giant cells and even epithe-
lial and connective tissue elements (see
Yoffey and Courtice, 1970). The glomer-
ular mesangeitis produced rapidly by the
nephrotoxic action of ALS on the kidney
(Lindquist et al., 1969) may be a further
example of the nonspecific action of ALS
on tissues.
The suppressive effects of WBI of
host on the primary response to an allo-
graft cain be attributed largely to the
destruction of bone marrow which pre-
vents the elaboration ofimmunocompetent
cells. This action should prevail at any
age and decrease the primary immune
response to macrocolony growth of anti-
genic tumour cells in the lungs, but our
experiments have clearly shown that
sublethal WBI did not decrease materially
the resistance of older rats to macro-
colony growth of tumour. Furthermore,
when the injection of tumour cells was
delayed for some days after WBI, CFE
rose and at a time when regeneration of
bone marrow and other immunocytic
tissues (spleen, thymus) was progressing
and the blood leucocyte count had been
restored to near-normal. Also significant
has been our finding that local irradiation
of the lungs could be as effective as WBI
in increasing tumour CFE in lungs of
weanling rats and given under appropria-
tion conditions completely reversed the
resistance of older rats to growth of a
primary inoculum in the lungs (to be
published).
In attempting to explain our results,
it seems possible that these two tumours
possess certain histoincompatibility anti-
gens to which weanling rats react weakly
and that this reaction develops rapidly
after weaning. Thus, immunoelectro-
phoretic studies of the antigenic profile
of Yoshida sarcoma by Caputo (1.969)
showed the presence of several nonspecific
components in addition to " Y1" and
"Y3" organ specific antigens and a
" 2 tumour specific antigen occurring
in both microsomal and mitochondrial
cell fractions. But such " maturation "
of immunological competence does not
appear to explain completely continued
susceptibility ofolder rats to growth ofthe
tumour in muscle although it appears
reasonable to assume that single cells
which arrest " physiologically " in the
lung, would be more vulnerable to any
immune attack the host can offer than a
" consortium " of the cells in muscle
where trauma produced by inoculation
may help to shield the inoculum from
humoral defences. This argument can
also be advanced to account for the break-
down of resistance to clonogenic growth
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of cells in locally irradiated tissues where
inflammatory reactions conceivably corn-
pete for " immunocytes ", or the products
of inflammation catuse target cells to
become less accessible to immunocytic
destruction, or possibly interfere with
immunochemic,al mechanisms (e.g. avail-
ability of complement).
A further possibility whichi we feel
should not be excluded is that " growth
stimulating substances" (GSS) of a non-
specific nature are conducive to growth
and suirvival of cells (in vitro and in vivo)
and that tissue maturation with ageing
may bring about low local concentrations
of GSS -which causes single tumour cells
to grow poorly a situation not based on
immunity. The role of GSS in stimulat-
ing proliferative cell growth has been
demonstrated in a variety of biological
situations, in vitro and in vivo, including
the continued production of (4SS by
heavily irradiated (HR) cells which stimu-
lates tumour growth in vitro (Puck and
Marcus, 1956) and in vivo (Revesz, 1958;
van den Brenk and Shlarpington, 1971b),
a "leucocyte stimulating factor " in
granulopoiesis (Metcalf, 1 970) which is
also present in serum of irradiated mice
(Morley et al., 1971; Rickard et al.,
1971a, b), a portal blood factor acting as a
hlutmoral agent in liver regeneration (Fisher
et al., 1971), a HeLa cell stimulating factor
in normal calf serum (Salmon and Hosse,
1971) and polyaminies derived from orni-
thine in tissues which stimulate normal
aand neoplastic growth (Tabor and Tabor,
1964; Bucher and Malt, 1971). Condi-
tioning of the cellular enivironment by
GSS produced by host tissues in situ may
be a positive factor which " competes
with any immuine reaction of the body to
" take " and growth of tumour cells, and
facilitates the ease with which grafted
cells survive and begin to proliferate.
Once replication of the sequestrated
(tumour) cell is under way, a colony arises
whiicl itself produces GSS for growth to
continue. Increase in population density
of the colony wouild not onily decrease the
accessibility of its innermost cells to the
destructive actions of immunocytes and
their products, but, vis a tergo would
stimulate growth in the colony by generat-
ing GSS in situ. It seems likely that
ALS, like certain other heterologous sera
and proteins (e.g. phytohaemagglutin),
has blastogenic and growth stimulating
actions in vivo, besides acting as an immu-
nosuppressant. Conceivably, growth
stimulating effects may help to promote
tumour growth in allogeneic and syngeneic
hosts. Reactions to tissue damage caused
by irradiation lead to hyperplastic
(regenerative) changes which also possibly
cause GSS levels to rise. The finding that
delaying inoculation after WABI of older
rats increased tumour CFE in lungs would
be in accord with this concept ofcondition-
ing by8 GSS and recent experiments (to be
published) have shown that stimulation
of growth after local lung irradiation also
depends on the delay between irradiation
and inoculation; by appropriately adjust-
ing the radiation dose and the radiation-
inoculation interval, resistance of older
rats to tumour macrocolony growth in
lung could be inhibited. Colony regres-
sion seen to occur in older rats is also
considered to arise from stimulation of
growth in the first instance, followed by
suppression later whenimmunosuppressive
forces dominate. A population ofactively
growing tumour cells provides the most
effective antigeneic stimulus to the host
(Haddow and Alexander, 1964), and this
stimulus would develop during the growth
of colonies. Low efficiencies of macro-
colony production could thus be attributed
to presence of microcolonies or to regres-
sion ofcolonies as well as to failed " takes "
from lack of support and stimulation of
cell growth. It seems significant that
older recipient animals were used by
Hill and Bush (1969), who also found that
HR cells (a source of antigen and poten-
tially capable of enhancing immunity)
greatly increased CFE.
Prehn (1972) has recently provided
further data in support of his theory
that the effect of immunity oii a target
tumour cell is biphasic and consists of
150MACROCOLONY ASSAYS IN THE RAT 151
both a mild reaction which stimulates
tumour growth and a strong cytotoxic
reaction. The nature of this stimulatory
component is not known but normal or
" sensitized " syngeneic spleen cells
brought into contact with the tumour
cells in vitro stimulated tumour growth,
at a critical spleen cell/tumour cell ratio
of approximately 104: 1, higher spleen/
tumour cell ratios inhibiting growth.
These findings seem similar in nature to
the effect of treating rats injected with
W-256 cells with an excess ofnormal bone
marrow cells (Fig. 7). A cytotoxic action
against fewer tumour cells predominated,
whereas take and growth of a larger
number of inoculated tumour cells were
stimulated by normal bone marrow but
not by sensitized bone marrow.
In conclusion, it is clear that the use of
a non-antigenic or weakly antigenic
tumour in syngeneic or immunosuppressed
hosts for macrocolony assays does not
necessarily ensure high CFE. CFE is not
affected significantly by sex of host, but
mean lung colony numbers obtained in
assays show large variances and individual
lung colony counts do not conform to a
Poisson distribution. The reasons for
this variation are obscure but are not
due simply to differences in immuno-
logical compatibility. The age ofanimnals
used in assays greatly affects CFE. This
effect could not bereconciled withincreases
in body weight and lung volume with
increase in age of rat. Animal age needs
to be carefully controlled if results of cell
assays are to have quantitative signifi-
cance and other suitable measures which
raise CFE (including immunosuppressant
therapy) must betaken. Various attempts
were madetoimproveCFE. Splenectomy,
steroid therapy, depletion oftissue amines
by compound 48/80, saturation of the
granulopectic functions of the RES by
india ink and treatment with cytotoxic
drugs were ineffective; only WBI or ALS
raised CFE. The rise in CFE produced by
these treatments is considered due not
only to immunosuppressant actions but
also to a local " conditioning" by the
agent ofthe tumour cell bed, which allows
" take " and early replication of tumour
cells to occur more readily.
REFERENCES
BASERGA, R., PUTONG, P. B., TYLER, S. & WARTMAN,
W. B. (1960) The Dose-Response Relationship
between the Number of Embolic Tumour Cells
and the Incidence of Blood-borne Metastases.
Br. J. Cancer, 14, 173.
Biozzi, G., BENACERRAF, B. & HALPERN, B. N.
(1953) Quantitative Study of the Granulopectic
Activity of the Reticuloendothelial System. II.
A Study of the Kinetics of the Granulopectic
Activity of the RES in Relation to the Dose of
Carbon Injected. Relationship between the
Weight of the Organs and their Activity. Br. J.
exp. Path., 34, 441.
BOYD, J. F. & SMITH, A. N. (1960) The Effect of
Compound 48/80 on the Autograft and Homo-
graft Reaction. Br. J. exp. Path., 41, 259.
BUCHER, N. L. R. & MALT, R. A. (1971) Regeneration
ofLiver and Kidney. Boston: Little, Brown & Co.
CAPUTO, A. (1969) Antigens of Yoshida Tumour
Cells. J. Path., 97, 639.
FELDBERG, W. & TALESNIK, J. (1953) Reduction of
Tissue Histamine by Compound 48/80. J.
Physiol., 120, 550.
FISHER, B., SOLIMAN, D. & FISHER, E. R. (1969)
Effect of Antilymphocyte Serum on Parameters
ofTumour Growth in a Syngeneic Tumour-Host
System. Proc. Soc. exp. Biol. Med., 130, 16.
FISHER, B., SzucH, P., LEvEUE, M. & FISHER, E. R.
(1971) A Portal Blood Factor as the Humoral
Agent in Liver Regeneration. Science, N. Y.,
171, 575.
GUTTMANN, R. D., CARPENTER, C. B., LINDQuIsT,
R. R. & MERRILL, J. P. (1967) Treatment with
Heterologous Antithymus Sera: Nephritis Associ-
ated with Modification of Renal Allograft Rejec-
tion and the Immune Status of the Host to the
Foreign protein. Transplantation, 5, 1115.
HADDOW, A. & ALEXANDER, P. (1964) An Immuno-
logical Method of Increasing the Sensitivity of
Primary Sarcomas to Local Irradiation with
X-ray. Lancet, i, 452.
HEWITT, H. B. (1953) The Effect of Age of Host on
the Quantitative Transplantation of Sarcoma 37.
Br. J. Cancer, 7, 384.
HILL, R. P. & BUSH, R. S. (1969) A Lung-colony
Assay to Determine Radiosensitivity of the Cells
of a Solid Tumour. Int. J. Radiat. Biol., 15, 435.
HUXLEY, J. S. (1932) Problems of Relative Growth.
New York: Dial Press.
LEVEY, R. H. & MEDAWAR, P. B. (1966) Some
Experiments on the Action of Antilymphoid
Antisera. Ann. N.Y. Acad. Sci., 129, 164.
LINDQUIST, R. R., GUTTMANN, R. D., CARPENTER,
C. B. & MERRILL, J. P. (1969) Nephritis Induced
by Antilymphocyte Serum. Transplantation, 8,
545.
METCALF, D. (1970) Studies of Colony Formation
in vitro by Mouse Bone Marrow Cells. II.
Action of Colony Stimulating Factor. J. cell.
comp. Physiol., 76, 89.
MORLEY, A., RICKARD, K. A., HOWARD, D. &
STOHLMAN, F. (1971) Studies on the Regulation152 H. A. S. VAN DEN BRENK, C. SHARPINGTON AND C. ORTON
of Granulopoiesis IV. Possible Humoral Regula-
tion. Blood, 37, 14.
PATTERSON, J. T., PISANO, J. C. & Di Luzio, N. R.
(1970) Reversal of Antilymphocytic Serum-
induced Immunosuppression by Macrophage
Administration. Proc. Soc. exp. Biol. Med.,
135, 831.
PRERN, R. T. (1972) The Immune Reaction as a
Stimulation of Tumour Growth. Science, N.Y.,
176, 170.
PucK, T. T. & MARCus, P. I. (1956) Action of
X-rays on Mammalian Cells. J. exp. Med., 103,
653.
REvEsz, L. (1958) Effect of Lethally Damaged
Tumour Cells upon the Development of Admixed
Viable Cells. J. natn. Cancer Inst., 20, 1157.
RicHEs, A. C. & THOMAS, D. B. (1970) The Growth
of Allogeneic Tumour Implants as an Index of
Immunosuppression. J. Anat., 107,392.
RICKARD, K. A., MORLEY, A., HOWARD, D.,
GARRITY, M. & STOHLMAN, F. (1971a) Stem Cell
Stimulatory Properties in vitro of an Agar
Colony-stimulating Factor. Proc. Soc. exp. Biol.
Med., 136, 608.
RICKARD, K. A., MORLEY, A., HOWARD, D. &
STOHLMAN, F. (1971b) The in vitro Colony-
forming Cell and the Response to Neutropenia.
Blood, 37, 6.
SALMON, W. D. & HossE, B. R. (1971) Stimulation
of HeLa Cell Growth by a Serum Fraction with
Sulfation Factor Activity. Proc. Soc. exp. Biol.
Med., 136, 805.
TABOR, H. & TABOR, C. W. (1964) Spermidine,
Spermine and Related Amines. Pharmac. Rev.,
16, 245.
VAN DEN BRENK, H. A. S., MOORE, V. & SHARPING-
TON, C. (1971a) Growth of Metastases from
P-388 Sarcoma in the Rat following Whole Body
Irradiation. Br. J. Cancer, 25, 186.
VAN DEN BRENK, H. A. S., SPARROW, N. & MOORE,
V. (1969) Effect of X-radiation on Salivary
growth in the Rat. 1. Effect of Single Doses on
Post-natal Differentiation and Growth of Acinar
and Duct Components. Int. J. Radiat. Biol., 16,
241.
VAN DEN BRENK, H. A. S. & SHARPINGTON, C.
(1971b) Effect of Local X-irradiation of a Primary
Sarcoma in the Rat on Dissemination and Growth
of Metastases: Dose-Response Characteristics.
Br. J. Cancer, 25, 812.
VAN DEN BRENK, H. A. S. & UPFILL (1958) Hetero-
logous Growth of Ehrlich Ascites Tumour in
Histamine-depleted Rats. Aust. J. Sci., 21, 20.
WILLIAMS, J. F. & TILL, J. E. (1966) Formation of
Lung Colonies by Polyoma-transformed Rat
Embryo Cells. J. natn. Cancer Inst., 37, 177.
WOODRUFF, M. F. A. (1960) The Transplantation of
Tissues and Organs. Springfield, Ill.: Charles C.
Thomas.
YOFFEY, J. M. & COURTICE, F. C. (1970) Lymphatics,
LymphandtheLymphomyeloidComplex. London:
Academic Press.
ZEIDMAN, I., MCCUTCHEON, M. & COMAN, D. R.
(1950) Factors Affecting the Number of Tumour
Metastases. Experiment with a Transplantable
Mouse Tumour. Cancer Res., 10, 357.